107 related articles for article (PubMed ID: 7485095)
21. Blastoid lymphocyte transformation assay in malignant tumours of lymphopoietic tissue: in Hodgkin's disease, reticulosarcoma, lymphosarcoma and chronic lymphatic leukaemia. Relationship to the clinical status and to the delayed type of hypersensitivity.
Libánský J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):51-6. PubMed ID: 4128515
[No Abstract] [Full Text] [Related]
22. A study of antibody formation in patients with malignant lymphomas.
GELLER W
J Lab Clin Med; 1953 Aug; 42(2):232-7. PubMed ID: 13069869
[No Abstract] [Full Text] [Related]
23. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma].
Monzawa S; Karikomi M; Uno K; Itami J; Arimizu N
Gan No Rinsho; 1988 Aug; 34(9):1059-64. PubMed ID: 3172511
[TBL] [Abstract][Full Text] [Related]
24. CA 125 elevations in patients with malignant lymphomas.
Fehm T; Beck E; Valerius T; Gramatzki M; Jäger W
Tumour Biol; 1998; 19(4):283-9. PubMed ID: 9679739
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
Wu HY
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
[TBL] [Abstract][Full Text] [Related]
26. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
Kuleva SA
Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
[TBL] [Abstract][Full Text] [Related]
27. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
28. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
[TBL] [Abstract][Full Text] [Related]
29. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
[TBL] [Abstract][Full Text] [Related]
30. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
[TBL] [Abstract][Full Text] [Related]
31. Lack of HER-2/neu overexpression in non-Hodgkin's lymphoma.
Lüftner D; Genvresse I; Geppert R; Kaufmann O; Dietel M; Possinger K
Anticancer Res; 2004; 24(5B):3233-7. PubMed ID: 15510616
[TBL] [Abstract][Full Text] [Related]
32. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
33. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
Kim H; Nathwani BN; Rappaport H
Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
[TBL] [Abstract][Full Text] [Related]
34. [Behavior of the leukocyte sedimentation rate in malignant neoplasms, Hodgkin's disease and lympho-reticulosarcoma].
Colantuono A; Maccauro L
Rass Int Clin Ter; 1967 May; 47(9):491-504. PubMed ID: 4887990
[No Abstract] [Full Text] [Related]
35. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
36. Elevated hyaluronan blood concentrations in severely burned patients.
Onarheim H; Reed RK; Laurent TC
Scand J Clin Lab Invest; 1991 Dec; 51(8):693-7. PubMed ID: 1806984
[TBL] [Abstract][Full Text] [Related]
37. Ultrasound examination of pathological cervical lymph nodes in patients with non-Hodgkin's lymphoma and Hodgkin's disease.
Gerrits CJ; van Overhagen H; van Lom K; Adriaansen HJ; Löwenberg B
Br J Haematol; 1994 Nov; 88(3):626-8. PubMed ID: 7819079
[TBL] [Abstract][Full Text] [Related]
38. Alterations of plasma levels in malignant lymphoma.
Opat P; Rejthar A; Tomanová J; Trnka A; Wotke R
Neoplasma; 1981; 28(3):339-43. PubMed ID: 7290261
[TBL] [Abstract][Full Text] [Related]
39. Risk-adjusted prognostic models for Hodgkin's disease (HD) and grade II non-Hodgkin's lymphoma (NHL II): validation on 6728 British National Lymphoma Investigation patients.
Low SE; Horsman JM; Walters SJ; Hancock H; Smith P; Linch D; Hancock BW
Br J Haematol; 2003 Jan; 120(2):277-80. PubMed ID: 12542487
[TBL] [Abstract][Full Text] [Related]
40. Relation of bone marrow findings to serum protein changes in lymphosarcoma, chronic lymphocytic leukemia and Hodgkin's disease.
ONAT A; COOPER T
Blood; 1960 Jan; 15():114-29. PubMed ID: 14428869
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
